Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Downgrades DermTech to Market Perform

William Blair Downgrades DermTech to Market Perform

William Blair analyst Brian Weinstein downgrades DermTech (NASDAQ:DMTK) from Outperform to Market Perform.

byBenzinga Newsdesk

November 4, 2022

1 minute read

William Blair analyst Brian Weinstein downgrades DermTech (NASDAQ:DMTK) from Outperform to Market Perform.

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $11

By Benzinga Newsdesk

March 7, 8:25 AM

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $12 to $11.

OCUL

Industrial Technology Company Enpro Expands Critical Solutions With $210M AMI Acquisition

By Lekha Gupta

December 28, 10:11 AM

Enpro Inc (NYSE: NPO) penned a deal to acquire Advanced Micro Instruments, Inc.

NPO

Why Lordstown Motors Stock Is Tumbling Tuesday

By Adam Eckert

June 27, 8:45 AM

Lordstown Motors Corp (NYSE: RIDE) shares are trading lower Tuesday after the company opted to file for Chapter 11 bankruptcy protection.

RIDE

News

Target Says Supply Chain Conditions Still Remain Highly Unfavorable When Compared To The Years Before The Pandemic; Says This Year, We Expect To Meaningfully Reduce Our Reliance On Air Freight

By Benzinga Newsdesk

August 17, 8:36 AM

-Reuters

TGT

William Blair Downgrades DermTech to Market Perform

Related Posts

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $11

Industrial Technology Company Enpro Expands Critical Solutions With $210M AMI Acquisition

Why Lordstown Motors Stock Is Tumbling Tuesday

Target Says Supply Chain Conditions Still Remain Highly Unfavorable When Compared To The Years Before The Pandemic; Says This Year, We Expect To Meaningfully Reduce Our Reliance On Air Freight